Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caudal bupivacaine with dexmedetomidine, neostigmine, or midazolam for postoperative pain in children undergoing lower abdominal surgery
IRCT20230124057200N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bupivacaine, midazolam, neostigmine and dexmedetomidine in postoperative pain, sponsored by Arak University of Medical Sciences. Started Feb 2023; status: completed.
02
Drugs
bupivacainemidazolamneostigminedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20230124057200N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230124057200N1.